|
|
Article: Drug Prevents Eye Disease in Tests on Rats; Synthetic Version of Vitamin B1 Found to Block Diabetes-Related Retina Damage
- Article from:
- The Washington Post
- Article date:
- February 17, 2003
|
Copyright informationThis material is published under license from the Washington Post. All inquiries regarding rights should be directed to the Washington Post. (Hide copyright information)
|
A synthetic form of vitamin B1 that is used in Europe to treat
nerve problems has been found to prevent the most common form of
diabetes-related eye disease in rats.
Diabetic rats treated with benfotiamine for 36 weeks did not
develop any of the retina damage found in a similar group of
untreated rats, according to a research team led by Michael Brownlee
of the Albert Einstein College of Medicine in New York.
Brownlee said he hopes to begin a clinical trial to determine
whether a similar result would occur in humans once an effective dose
for the drug in people is determined. That could happen in as soon as
a year, he said.
"We can't say it works in humans because there has never been a ...
Related newspaper, magazine, and journal articles:
|
|
Article: SECRETARY BROWNLEE VISITS SOLDIERS IN IRAQ
Regulatory Intelligence Data;
August 27, 2004 ;
645 words
......Acting Secretary of the Army Les Brownlee met with Soldiers of the 1st Cavalry...Baghdad and Kirkuk Air Base Aug. 27. Brownlee and Maj. Gen. Peter Chiarelli, 1st Cavalry...the division's headquarters in Baghdad. Brownlee was told how the MARCBOT helps troops...
|
|